News 30 Apr 2025 Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz
Scientific articles 29 Apr 2025 Fexinidazole as a new oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense: A prospective, open-label, single-arm, Phase II–III, non-randomised study The Lancet Global Health
Scientific articles 29 Apr 2025 Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: A phase IIIb, prospective, open-label, non-randomised, cohort study The Lancet Global Health
News 25 Apr 2025 Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi
Press releases 24 Apr 2025 Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease
In the media 23 Apr 2025 Race against time: New treatment for deadly HIV complication enters trials Daily Nation
Press releases 23 Apr 2025 DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease
Scientific articles 21 Apr 2025 A balancing act: Navigating the advantages and challenges of pioneering mycetoma treatment in Sudan – A landmark trial by the Mycetoma Research Center PLOS Neglected Tropical Diseases
Scientific articles 17 Apr 2025 Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted network The Lancet Child & Adolescent Health
In the media 17 Apr 2025 New treatment for deadly HIV-linked meningitis enters phase II trial The Standard
In the media 17 Apr 2025 Un nouveau traitement contre la méningite à cryptocoque, en phase d’essai RTS
In the media 16 Apr 2025 Accord historique à l’OMS sur la préparation et la lutte contre les futures pandémies AFP
In the media 16 Apr 2025 Luz verde para un “histórico” tratado mundial contra pandemias impulsado por la OMS El País
Press releases 17 Jan 2019 Combination therapy found to be more effective in treating patients with leishmaniasis and HIV
Press releases 16 Nov 2018 European Medicines Agency recommends fexinidazole, the first all-oral treatment for sleeping sickness
Press releases 12 Sep 2018 New hope for PKDL patients in Africa as clinical trial aims to make treatment safer and easier
Press releases 5 Sep 2018 DNDi and Fiocruz launch project to expand access to diagnosis and treatment for Chagas disease in Brazil
Press releases 23 Jul 2018 FIND and DNDi team up to support Malaysian MOH efforts to simplify and decentralize hepatitis C screening & treatment
Press releases 14 Apr 2018 DNDi agreement with Colombia Ministry of Health and Social Welfare to guarantee access to comprehensive care for Chagas patients
Press releases 13 Apr 2018 Clinical trial to find new treatment for visceral leishmaniasis begins in eastern Africa
Press releases 5 Apr 2018 Takeda Pharmaceutical and DNDi collaborate to progress a potential new drug for visceral leishmaniasis through the R&D pipeline
Press releases 27 Mar 2018 DNDi, GlaxoSmithKline, and University of Dundee to identify drug candidates to treat leishmaniasis and Chagas disease
Press releases 5 Mar 2018 Pharmaceutical companies and non-profits team up to provide affordable hepatitis C treatment in Latin America
Press releases 31 Jan 2018 Sanofi, DNDi seek European Medicines Agency review for sleeping sickness treatment
Press releases 13 Nov 2017 Pharmaniaga, Pharco and DNDi sign agreement to provide affordable hepatitis C treatment in Malaysia
Press releases 8 Nov 2017 DNDi/GARDP opens new South Africa liaison office, hosted by South African Medical Research Council
